Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Sep;14(5):1627-1628.
doi: 10.1111/cts.13026. Epub 2021 May 1.

Antinuclear antibodies in COVID 19

Paolo Muratori  1   2 , Marco Lenzi  1   3 , Luigi Muratori  1   3 , Alessandro Granito  1   3
Affiliations
Comment

Antinuclear antibodies in COVID 19

Paolo Muratori et al. Clin Transl Sci. 2021 Sep.
No abstract available

PubMed Disclaimer

Conflict of interest statement

All authors declared no competing interests for this work.

Figures

FIGURE 1
FIGURE 1
Substrate: Hep‐2 cells, magnification ×40. Diffuse nucleoli positivity (red arrows), presence of perichromosomal fluorescence during the mitotic phase (yellow arrow)
See this image and copyright information in PMC

Comment on

References

    1. Chang SH, Minn D, Kim YK. Autoantibodies in moderate and critical cases of COVID19 [published online ahead of print Mar 10, 2021]. Clin Transl Sci. https://doi.org/10.1101/2021.03.09.434529. - PMC - PubMed
    1. Pascolini S, Vannini A, Deleonardi G, et al. COVID‐19 and immunological dysregulation: can autoantibodies be useful? Clin Transl Sci. 2021;14(2):502‐508. - PMC - PubMed
    1. Granito A, Muratori P, Muratori L, et al. Antibodies to SS‐A/Ro‐52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis. Aliment Pharmacol Ther. 2007;15(26):831‐838. - PubMed
    1. Gao Z‐W, Zhang H‐Z, Liu C, Dong KE. Autoantibodies in COVID‐19: frequency and function. Autoimmun Rev. 2021;20(3):102754. - PMC - PubMed
    1. Lerma LA, Chaudhary A, Bryan A, Morishima C, Wener MH, Fink SL. Prevalence of autoantibody responses in acute coronavirus disease 2019 (COVID‐19). J Transl Autoimmun. 2020;3:100073. - PMC - PubMed

Substances